A MULTILATERAL APPROACH TO COPD COMORBIDITIES

A. Corlateanu (Chisinau, Republic of Moldova), S. Covantev (Chisinau, Republic of Moldova), E. Scutaru (Chisinau, Republic of Moldova), D. Rusu (Chisinau, Republic of Moldova), O. Corlateanu (Chisinau, Republic of Moldova), V. Botnaru (Chisinau, Republic of Moldova)

Source: International Congress 2018 – COPD and extrapulmonary comorbidities
Session: COPD and extrapulmonary comorbidities
Session type: Thematic Poster
Number: 4034
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Corlateanu (Chisinau, Republic of Moldova), S. Covantev (Chisinau, Republic of Moldova), E. Scutaru (Chisinau, Republic of Moldova), D. Rusu (Chisinau, Republic of Moldova), O. Corlateanu (Chisinau, Republic of Moldova), V. Botnaru (Chisinau, Republic of Moldova). A MULTILATERAL APPROACH TO COPD COMORBIDITIES. 4034

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
ASSESSMENT OF HEALTH-RELATED QUALITY OF LIFE IN DIFFERENT PHENOTYPES OF COPD
Source: International Congress 2017 – Management of asthma in different situations
Year: 2017


PERCEPTION OF CAREGIVERS ON THE CARE OF PATIENTS WITH COPD IN USE OF LTOT
Source: International Congress 2017 – Nursing practice across respiratory care pathways
Year: 2017


COPD DIAGNOSIS: DIFFERENCES ACCORDING GENDER
Source: Virtual Congress 2021 – Primary care organisation and epidemiology
Year: 2021


DOES THE BENEFIT FROM PULMONARY REHABILITATION DIFFER BETWEEN PHENOTYPES IN COPD?
Source: Virtual Congress 2020 – Reviews and novel insights into pulmonary rehabilitation
Year: 2020

VALIDATION OF AN ASSESSMENT TOOL FOR CONTROL IN COPD: ANALYSIS OF CLINICAL VARIABLES.
Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD?
Year: 2018



TREATMENT-RELATED DETERMINANTS OF THE RESPIRATORY MICROBIOME IN COPD
Source: Virtual Congress 2020 – Clinical studies of COPD: combination inhalers and much more
Year: 2020


ARE THERE CLINICALLY RELEVANT BENEFITS IN A STRUCTURED PROGRAM OF PHYSICAL ACTIVITY IN COPD? ACTIVEPOC STUDY.
Source: Virtual Congress 2020 – Pulmonary rehabilitation across the globe
Year: 2020


ARE THERE DIFFERENCES IN EXERCISE CAPACITY BY GENDER IN COPD PATIENTES?
Source: Virtual Congress 2020 – COPD phenotypes
Year: 2020


IMPACT OF IPF PATIENT SUPPORT PROGRAM IN QUALITY OF LIFE
Source: Virtual Congress 2020 – What is hot in idiopathic pulmonary fibrosis?
Year: 2020


SERUM ?-2-MICROGLOBULIN CORRELATES WITH COPD OUTCOMES AND PREDICTS FUTURE HOSPITALIZATION.
Source: Virtual Congress 2020 – Diagnosis and management of COPD
Year: 2020


RATES OF LUNG FUNCTION DECLINE DIFFERS BETWEEN COPD PHENOTYPES
Source: Virtual Congress 2020 – COPD phenotypes
Year: 2020


BACTERIAL IMMUNOTHERAPY IN COPD AND/OR BRONCHIECTASIS FREQUENT EXACERBATOR PATIENTS. A RETROSPECTIVE STUDY.
Source: International Congress 2018 – Integrated care and non-pharmacological management of COPD
Year: 2018

BODE INDEX IN DIFFERENT PHENOTYPES OF COPD
Source: International Congress 2017 – What is new in COPD diagnosis and classification?
Year: 2017


PAIN AND FRAILTY IN COPD PATIENTS: RELATIONSHIP AND IMPACT ON WELLBEING AND HEALTH STATUS
Source: International Congress 2018 – Patient-reported outcomes and scores in COPD
Year: 2018

IMPACT OF COMORBIDITY ON SLEEP QUALITY IN COPD PATIENTS EVALUATED WITH THE PITTSBURGH SLEEP QUALITY INDEX (PSQI)
Source: International Congress 2018 – From continuous positive airway pressure (CPAP) and adherence to CPAP to asthma-COPD overlap syndrome (ACOS)
Year: 2018

USEFULNESS OF MIRNAS AS PREDICTORS OF LUNG CANCER IN PATIENTS WITH COPD. A PILOT SUTDY
Source: Virtual Congress 2021 – Mechanistic pathways in chronic and new lung diseases
Year: 2021



Late Breaking Abstract - RHEOLOGY AS A TOOL TO ASSESS COPD DIAGNOSIS COMPARED TO ASTHMA DIAGNOSIS, AND TO EVALUATE THE EFFICIENCY OF TREATMENTS
Source: International Congress 2017 – Late-breaking findings in asthma and COPD
Year: 2017


NEUROMUSCULAR EFFICIENCY DURING EXERCISE IN COPD PATIENTS
Source: International Congress 2019 – Exploring exercise responses in respiratory diseases
Year: 2019


IMPACT OF COMORBIDITY ON DIRECT MEDICAL COSTS OF COMMUNITY-ACQUIRED PNEUMONIA (CAP)
Source: International Congress 2017 – Does economisation of medicine transfer into benefits for patients?
Year: 2017


MAINTAINING PULMONARY REHABILITATION EFFECTS IN COPD PATIENTS AT HOME – A PROTOCOL STUDY
Source: Virtual Congress 2020 – Challenges and updates in nursing care around the world
Year: 2020